![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Announces $12.4 Million Private Placement
08 oct. 2009 07h05 HE
|
Talon Therapeutics, Inc.
* Financing led by OrbiMed Advisors LLC, Perceptive Life Sciences
Master Fund Ltd., Quogue Capital LLC and Deerfield Management
* Proceeds to be used to advance Hana's lead clinical compound
...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Enters Into Clinical Trial Agreement With the National Cancer Institute for Development of Marqibo(R) in Pediatric Cancer
30 sept. 2009 07h05 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB) today announced that the Company has entered into a Clinical Trial Agreement (CTA) with the Center for...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Receives NASDAQ Delisting Notification
08 sept. 2009 19h33 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB) today announced that the Company received a letter from the Staff of The NASDAQ Stock Market indicating...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Announces Second Quarter 2009 Results
14 août 2009 17h45 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Reaches Patient Enrollment Target for Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
12 août 2009 07h05 HE
|
Talon Therapeutics, Inc.
56th Subject Enrolled and Dosed
Data Presentation Targeted for 2009 ASH Annual Meeting
NDA Submission Targeted for First Half of 2010
SOUTH SAN...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Presents Updated Marqibo Data At the American Society of Clinical Oncology Annual Meeting
02 juin 2009 06h30 HE
|
Talon Therapeutics, Inc.
* 30% CR/CRi Rate in First 33 rALLy Subjects
* rALLy Study Expected to Reach Target Enrollment by Mid-Year
* Encouraging Survival in Metastatic Uveal Melanoma Trial
SOUTH SAN FRANCISCO,...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Announces First Quarter 2009 Results
15 mai 2009 07h05 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 15, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Receives Going Concern Qualification
09 avr. 2009 17h53 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 9, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc., (Nasdaq:HNAB), a biopharmaceutical company focused on developing and commercializing new, differentiated cancer...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences Reports Fourth Quarter and Full Year 2008 Results
31 mars 2009 16h05 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 31, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences Inc., (Nasdaq:HNAB), a biopharmaceutical company focused on developing and commercializing new, differentiated cancer...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Hana Biosciences to Report Fourth Quarter and Full Year 2008 Financial Results On March 31, 2009
18 mars 2009 07h30 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB) will announce its fourth quarter and full year 2008 results on Tuesday, March 31, 2009, after the close...